WallStSmart

CubeSmart (CUBE)vsSabra Healthcare REIT Inc (SBRA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CubeSmart generates 39% more annual revenue ($1.13B vs $815.66M). CUBE leads profitability with a 28.9% profit margin vs 19.2%. SBRA appears more attractively valued with a PEG of 5.28. SBRA earns a higher WallStSmart Score of 59/100 (C).

CUBE

Hold

49

out of 100

Grade: D+

Growth: 3.3Profit: 8.0Value: 5.3Quality: 3.0
Piotroski: 2/9Altman Z: 0.43

SBRA

Buy

59

out of 100

Grade: C

Growth: 5.3Profit: 7.0Value: 6.0Quality: 5.5
Piotroski: 3/9Altman Z: 0.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CUBEUndervalued (+27.0%)

Margin of Safety

+27.0%

Fair Value

$52.92

Current Price

$40.31

$12.61 discount

UndervaluedFair: $52.92Overvalued
SBRAUndervalued (+84.2%)

Margin of Safety

+84.2%

Fair Value

$124.38

Current Price

$18.46

$105.92 discount

UndervaluedFair: $124.38Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CUBE2 strengths · Avg: 9.5/10
Operating MarginProfitability
40.3%10/10

Strong operational efficiency at 40.3%

Profit MarginProfitability
28.9%9/10

Keeps 29 of every $100 in revenue as profit

SBRA3 strengths · Avg: 8.7/10
Operating MarginProfitability
31.4%10/10

Strong operational efficiency at 31.4%

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.7%8/10

Revenue surging 21.7% year-over-year

Areas to Watch

CUBE4 concerns · Avg: 3.5/10
P/E RatioValuation
29.3x4/10

Moderate valuation

Revenue GrowthGrowth
3.3%4/10

3.3% revenue growth

Debt/EquityHealth
1.323/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

SBRA4 concerns · Avg: 3.0/10
P/E RatioValuation
29.7x4/10

Moderate valuation

Return on EquityProfitability
5.6%3/10

ROE of 5.6% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
5.282/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CUBE

The strongest argument for CUBE centers on Operating Margin, Profit Margin. Profitability is solid with margins at 28.9% and operating margin at 40.3%.

Bull Case : SBRA

The strongest argument for SBRA centers on Operating Margin, Price/Book, Revenue Growth. Profitability is solid with margins at 19.2% and operating margin at 31.4%. Revenue growth of 21.7% demonstrates continued momentum.

Bear Case : CUBE

The primary concerns for CUBE are P/E Ratio, Revenue Growth, Debt/Equity.

Bear Case : SBRA

The primary concerns for SBRA are P/E Ratio, Return on Equity, Piotroski F-Score.

Key Dynamics to Monitor

CUBE profiles as a value stock while SBRA is a growth play — different risk/reward profiles.

CUBE carries more volatility with a beta of 1.08 — expect wider price swings.

SBRA is growing revenue faster at 21.7% — sustainability is the question.

CUBE generates stronger free cash flow (149M), providing more financial flexibility.

Bottom Line

SBRA scores higher overall (59/100 vs 49/100), backed by strong 19.2% margins and 21.7% revenue growth. CUBE offers better value entry with a 27.0% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CubeSmart

REAL ESTATE · REIT - INDUSTRIAL · USA

CubeSmart is a self-managed and self-managed real estate investment trust.

Visit Website →

Sabra Healthcare REIT Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 skilled nursing / transitional care facilities, (ii) 64 senior housing communities (?

Want to dig deeper into these stocks?